BIOCRYST PHARMACEUTICALS, INC. Total Liabilities
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Total Liabilities of $1.01 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-05
- 2026-06-30: Liabilities $1.01B.
- 2026-03-31: Liabilities $1.02B.
- 2025-12-31: Liabilities $633.31M.
- 2025-09-30: Liabilities $834.31M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $1.01B 10-Q · filed 2026-08-05 |
| 2026-03-31 | $1.02B 10-Q · filed 2026-05-06 |
| 2025-12-31 | $633.31M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $834.31M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $878.78M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $931.97M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $966.35M 10-K · filed 2026-02-26 |
| 2024-09-30 | $959.82M 10-Q · filed 2024-11-05 |
| 2023-12-31 | $972.49M 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |